✦ LIBER ✦

A randomised phase II study of docetaxel/oxaliplatin and docetaxel in patients with previously treated non-small cell lung cancer: An Alpe–Adria Thoracic Oncology Multidisciplinary group trial (ATOM 019)

✍ Scribed by Ornella Belvedere; Alessandro Follador; Ciro Rossetto; Valentina Merlo; Carlotta Defferrari; Angela M. Sibau; Marianna Aita; Maria G. Dal Bello; Stefano Meduri; Marica Gaiardo; Gianpiero Fasola; Francesco Grossi

Book ID: 116430716
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 249 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2011.03.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of irinotecan and docetax

Phase II study of irinotecan and docetaxel in patients with previously treated non-small cell lung cancer: An Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 007)

✍ Grossi, Francesco; Fasola, Gianpiero; Rossetto, Ciro; Spizzo, Riccardo; Meduri, 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 105 KB

125PD FINAL REPORT OF A RANDOMIZED PHASE

125PD FINAL REPORT OF A RANDOMIZED PHASE II STUDY OF DOCETAXEL/OXALIPLATIN (DO) AND DOCETAXEL (D) IN PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS). AN ALPE-ADRIA THORACIC ONCOLOGY MULTIDISCIPLINARY GROUP STUDY (ATOM 019)

✍ Belvedere, O.; Follador, A.; Rossetto, C.; Sibau, A.M.; Rizzato, S.; Defferrari, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 89 KB

P-29 Phase II study of irinotecan plus d

P-29 Phase II study of irinotecan plus docetaxel in previously treated non-small cell lung cancer (NSCLC) patients: preliminary results. An Alpe Adria thoracic oncology multidisciplinary group study (ATOM 007)

✍ Fasola, Gianpiero; Belvedere, Ornella; Spizzo, Riccardo; Sibau, Angela; Meduri, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 180 KB

A randomised phase II trial of docetaxel

A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb–IV non-small-cell lung cancer who failed first-line treatment

✍ Wachters, F M; Groen, H J M; Biesma, B; Schramel, F M N H; Postmus, P E; Stigt, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 116 KB

A multicenter phase II study of carbopla

A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trial

✍ Masao Ichiki; Masayuki Kawasaki; Koichi Takayama; Kiyoshi Ninomiya; Mutsuo Kuba; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 211 KB

O-095 A phase III trial of docetaxel/car

O-095 A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small cell lung cancer — A randomised multicentre trial of the British thoracic oncology group (BTOG1)

✍ Lorigan, P. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB